Silvergate Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
Silvergate Pharmaceuticals General Information
Description
Reformulator of adult pharmaceuticals for the pediatric market. The company is engaged in reformulating adult pharmaceuticals into concentrations that are safe for children.
Contact Information
Website
www.silvergatepharma.comCorporate Office
- 6251 Greenwood Plaza Boulevard
- Suite 101
- Greenwood Village, CO 80111
- United States
Corporate Office
- 6251 Greenwood Plaza Boulevard
- Suite 101
- Greenwood Village, CO 80111
- United States
Silvergate Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Silvergate Pharmaceuticals Comparisons
Industry
Financing
Details
Silvergate Pharmaceuticals Competitors (16)
One of Silvergate Pharmaceuticals’s 16 competitors is Helsinn Healthcare, a Corporation company based in Lugano, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Helsinn Healthcare | Corporation | Lugano, Switzerland | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Indivior | Corporate Backed or Acquired | North Chesterfield, VA | ||||
| Regeneron Pharmaceuticals | Formerly VC-backed | Tarrytown, NY |
Silvergate Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Silvergate Pharmaceuticals Patents
Silvergate Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3096101-A1 | Amlodipine formulations | Pending | 11-Apr-2018 | ||
| EP-3773574-A1 | Amlodipine formulations | Active | 11-Apr-2018 | ||
| EP-3773574-A4 | Amlodipine formulations | Active | 11-Apr-2018 | ||
| EP-3773574-B1 | Amlodipine formulations | Active | 11-Apr-2018 | ||
| EP-3773574-C0 | Amlodipine formulations | Active | 11-Apr-2018 | A61K31/451 |
Silvergate Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Silvergate Pharmaceuticals FAQs
-
When was Silvergate Pharmaceuticals founded?
Silvergate Pharmaceuticals was founded in 2010.
-
Where is Silvergate Pharmaceuticals headquartered?
Silvergate Pharmaceuticals is headquartered in Greenwood Village, CO.
-
What industry is Silvergate Pharmaceuticals in?
Silvergate Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Silvergate Pharmaceuticals a private or public company?
Silvergate Pharmaceuticals is a Private company.
-
What is Silvergate Pharmaceuticals’s current revenue?
The current revenue for Silvergate Pharmaceuticals is .
-
How much funding has Silvergate Pharmaceuticals raised over time?
Silvergate Pharmaceuticals has raised $26.2M.
-
Who are Silvergate Pharmaceuticals’s investors?
Escalate Capital Partners and Frazier Healthcare Partners have invested in Silvergate Pharmaceuticals.
-
Who are Silvergate Pharmaceuticals’s competitors?
Helsinn Healthcare, Pfizer (Vienna), Pfizer Pakistan, Indivior, and Regeneron Pharmaceuticals are some of the 16 competitors of Silvergate Pharmaceuticals.
-
When was Silvergate Pharmaceuticals acquired?
Silvergate Pharmaceuticals was acquired on 01-May-2019.
-
Who acquired Silvergate Pharmaceuticals?
Silvergate Pharmaceuticals was acquired by Azurity Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
